FA
MRK icon

Faithward Advisors’s Merck MRK Stock Holding History

Faithward Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
9,353
-270
-3% -$31.6K 0.15% 132
2026
Q1 		$1.16M Buy
9,623
+2,430
+34% +$281K 0.17% 112
2025
Q4 		$757K Sell
7,193
-406
-5% -$38.1K 0.11% 151
2025
Q3 		$638K Sell
7,599
-312
-4% -$25.7K 0.09% 150
2025
Q2 		$626K Sell
7,911
-1,163
-13% -$92.4K 0.1% 139
2025
Q1 		$814K Buy
9,074
+278
+3% +$26K 0.14% 120
2024
Q4 		$875K Sell
8,796
-889
-9% -$91.7K 0.15% 110
2024
Q3 		$1.1M Sell
9,685
-698
-7% -$82.9K 0.19% 106
2024
Q2 		$1.29M Buy
10,383
+241
+2% +$31K 0.23% 101
2024
Q1 		$1.34M Buy
10,142
+4,610
+83% +$568K 0.24% 92
2023
Q4 		$698K Buy
5,532
+1,019
+23% +$106K 0.15% 101
2023
Q3 		$462K Buy
4,513
+132
+3% +$14.2K 0.11% 113
2023
Q2 		$471K Buy
4,381
+2,122
+94% +$241K 0.11% 105
2023
Q1 		$266K Buy
+2,259
New +$244K 0.06% 156

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Faithward Advisors's MRK Position: Q2 2026 in Review

Faithward Advisors reduced its Merck (MRK) stake by 2.8% in Q2 2026, selling an estimated $31.6K and leaving 9,353 shares worth $1.2M. The position accounts for 0.15% of the portfolio, ranked #132.

Faithward Advisors first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.34M in Q1 2024. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Faithward Advisors held 9,353 shares of Merck worth $1.2M as of Q2 2026.
  • Faithward Advisors sold 270 Merck shares in Q2 2026, an estimated $31.6K.
  • Merck made up 0.15% of Faithward Advisors's portfolio in Q2 2026, its #132 holding.
  • Faithward Advisors first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • Faithward Advisors's Merck position peaked at $1.34M in Q1 2024.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.